Lymphoma is among the malignancies at high risk of venous thromboembolism (VTE)1. The VTE risk is the highest upfront during the first month after lymphoma diagnosis and decreases over time2. This upfront risk may be related to tumor burden and start of chemotherapy as contributing factors.
Hohaus, S., Tisi, M. C., Bartolomei, F., Cuccaro, A., Maiolo, E., Alma, E., D'Alo', F., Bellesi, S., Rossi, E., De Stefano, V., Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization, <<BLOOD CANCER JOURNAL>>, 2018; 2018 (8): 54-57. [doi:10.1038/s41408-018-0096-1] [http://hdl.handle.net/10807/134151]
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization
Hohaus, StefanPrimo
;Tisi, Maria ChiaraSecondo
;Bartolomei, Francesca;Cuccaro, Annarosa;Maiolo, Elena;Alma, Eleonora;D'Alo', Francesco;Bellesi, Silvia;Rossi, ElenaPenultimo
;De Stefano, ValerioUltimo
2018
Abstract
Lymphoma is among the malignancies at high risk of venous thromboembolism (VTE)1. The VTE risk is the highest upfront during the first month after lymphoma diagnosis and decreases over time2. This upfront risk may be related to tumor burden and start of chemotherapy as contributing factors.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Hohaus-BloodCancerJournal2018.pdf
accesso aperto
Tipologia file ?:
Versione Editoriale (PDF)
Licenza:
Creative commons
Dimensione
304.79 kB
Formato
Adobe PDF
|
304.79 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
